Nalu Medical, Inc.
- Oct 9, 2024 · D/A · $115,059,232 sold of $115,059,232 · 29 investors · min. No minimum reported · role: Executive Officer EDGAR ↗
- Mar 27, 2024 · D/A · $85,059,242 sold of $85,059,242 · 29 investors · min. No minimum reported · role: Executive Officer EDGAR ↗
- Jan 5, 2024 · D · $64,999,958 sold of $79,999,953 · 16 investors · min. No minimum reported · role: Executive Officer EDGAR ↗
Raised $115.1M from 29 investors (100% of the $115.1M target) as of the latest filing. Jonathan is listed as executive officer on 3 filings for this deal.
Sources
Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.